Mylan, which was slammed by Congress for raising the price of the EpiPen, began selling a generic and cheaper version of the drug Friday.

The company said the generic EpiPen would be available for $300 for a two-pack, about half the cost of the $600 brand name version. In announcing the drug, Mylan acknowledged problems with high drug prices.